Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07562191. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07562191
Inhaled DMT for Major Depressive Disorder
This study is not yet recruiting. It focuses on depression and currently lists study information in Brazil.
DepressionOtherOver 18 Years
Key information made simple
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.
Your next step
The official record suggests in-person participation through a hospital, with sites including Hospital de Saúde Mental Professor Frota Pinto in Fortaleza, Complexo Hospitalar Universitário Professor Edgard Santos, Federal University of Bahia (HUPES-UFBA) in Salvador, and Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB-UFRJ) in Rio de Janeiro. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include safety concerns that need urgent care first and pregnancy or breastfeeding. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Sponsor type
- Unknown or unclear
- Main activity
- behavioral or lifestyle intervention
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- Inhaled DMT for Major Depressive Disorder
- Condition
- MDD; Major Depressive Disorder (MDD); Major Depression; Suicidal Ideation; Suicide
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Universidade Federal do Rio Grande do Norte
- Location / country
- Brazil
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07562191
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Brazil.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Inhaled DMT for Major Depressive Disorder
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07562191
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Inhaled DMT for Major Depressive Disorder?
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Universidade Federal do Rio Grande do Norte. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me